Correlation Between FrontView REIT, and Artiva Biotherapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both FrontView REIT, and Artiva Biotherapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FrontView REIT, and Artiva Biotherapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FrontView REIT, and Artiva Biotherapeutics, Common, you can compare the effects of market volatilities on FrontView REIT, and Artiva Biotherapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FrontView REIT, with a short position of Artiva Biotherapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of FrontView REIT, and Artiva Biotherapeutics,.

Diversification Opportunities for FrontView REIT, and Artiva Biotherapeutics,

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between FrontView and Artiva is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding FrontView REIT, and Artiva Biotherapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artiva Biotherapeutics, and FrontView REIT, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FrontView REIT, are associated (or correlated) with Artiva Biotherapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artiva Biotherapeutics, has no effect on the direction of FrontView REIT, i.e., FrontView REIT, and Artiva Biotherapeutics, go up and down completely randomly.

Pair Corralation between FrontView REIT, and Artiva Biotherapeutics,

Considering the 90-day investment horizon FrontView REIT, is expected to generate 1.05 times less return on investment than Artiva Biotherapeutics,. But when comparing it to its historical volatility, FrontView REIT, is 4.11 times less risky than Artiva Biotherapeutics,. It trades about 0.02 of its potential returns per unit of risk. Artiva Biotherapeutics, Common is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  1,200  in Artiva Biotherapeutics, Common on September 19, 2024 and sell it today you would lose (160.00) from holding Artiva Biotherapeutics, Common or give up 13.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy51.89%
ValuesDaily Returns

FrontView REIT,  vs.  Artiva Biotherapeutics, Common

 Performance 
       Timeline  
FrontView REIT, 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in FrontView REIT, are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, FrontView REIT, is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Artiva Biotherapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Artiva Biotherapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Artiva Biotherapeutics, is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

FrontView REIT, and Artiva Biotherapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with FrontView REIT, and Artiva Biotherapeutics,

The main advantage of trading using opposite FrontView REIT, and Artiva Biotherapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FrontView REIT, position performs unexpectedly, Artiva Biotherapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artiva Biotherapeutics, will offset losses from the drop in Artiva Biotherapeutics,'s long position.
The idea behind FrontView REIT, and Artiva Biotherapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Global Correlations
Find global opportunities by holding instruments from different markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments